Investment
Features
FeesSafety
Academy
More
Pluang+

Bond King Gundlach highlights Fed's tough choice: hiking rates worsens debt costs, cutting fuels inflation.

Market News
24 Sep 2026
Coindesk
View Source
Neutral
Bond King Gundlach highlights Fed's tough choice: hiking rates worsens debt costs, cutting fuels inflation.

Jeff Gundlach, founder of Doubleline Capital, explained the current bond market dilemma: if the Federal Reserve raises interest rates, it increases borrowing costs due to short-term debt exposure. Conversely, if the Fed cuts rates, it risks worsening inflation. This presents a challenging balancing act for the Fed as it tries to manage economic stability without exacerbating either problem.

The story on Bitcoin and bond yields is presented with a snapshot of cryptocurrency market activity on Pluang. As of Sep 24, 2026 18:21 WIB, out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable price changes include SXP down 46.27% at Rp37, ONE down 22.55% at Rp43 with a 40% sell order activity, and SNX down 11.47% at Rp4,146.

More News

XRP must break $1.57-$1.60 resistance to confirm bullish inverse head-and-shoulders pattern.

XRP must break $1.57-$1.60 resistance to confirm bullish inverse head-and-shoulders pattern.

XRP showed a potential bullish inverse head-and-shoulders pattern with a key resistance neckline near $1.57 and further resistance around $1.60. A decisive and sustained break above these levels is needed to strengthen the bullish case and target $2....

Technical Signals
Neutral
4 hours ago
Google partners with veterans groups to train 25,000 in skilled trades amid AI-driven demand surge

Google partners with veterans groups to train 25,000 in skilled trades amid AI-driven demand surge

Google announced a new initiative partnering with veterans organizations to help 25,000 veterans, service members, and military spouses enter skilled trades. This effort addresses a nationwide shortage of skilled trade workers driven by increased dem...

Market News
Bullish
4 hours ago
WHO approves 'Herlystic' as brand name for OS Therapies' cancer immunotherapy OST-HER2, enabling global regulatory filings.

WHO approves 'Herlystic' as brand name for OS Therapies' cancer immunotherapy OST-HER2, enabling global regulatory filings.

OS Therapies announced that the World Health Organization has approved 'Herlystic' as the brand name for its gene-edited cancer immunotherapy OST-HER2. With both the proprietary and nonproprietary names approved, the company is set to begin regulator...

Market News
Bullish
4 hours ago
XRP retreats from $1.70 resistance, testing support near $1.42 amid mixed signals for next move

XRP retreats from $1.70 resistance, testing support near $1.42 amid mixed signals for next move

XRP climbed from around $1.27 to test resistance between $1.61 and $1.70 but faced selling pressure that pushed it back to about $1.47. The token is currently testing a critical support zone around $1.42-$1.45, which overlaps with previous resistance...

Technical Signals
Neutral
4 hours ago
Ventripoint passes key quality and regulatory audits, supporting global market growth for its cardiac imaging tech.

Ventripoint passes key quality and regulatory audits, supporting global market growth for its cardiac imaging tech.

Ventripoint Diagnostics has successfully completed its annual quality and regulatory audits, including the Medical Device Single Audit Program, ISO 13485:2016, and the EU Medical Device Regulation. These audits confirm the effectiveness of Ventripoin...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App